中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
21期
6-7
,共2页
复方异丙托溴铵%布地奈徳%雾化吸入%症状%疗效
複方異丙託溴銨%佈地奈徳%霧化吸入%癥狀%療效
복방이병탁추안%포지내덕%무화흡입%증상%료효
Compound Isopropyl Bromide%Budesonide%Atomization inhalation%Symptoms%Curative effect
目的分析了解复方异丙托溴铵联合布地奈德雾化吸入治疗小儿毛细支气管炎的疗效和作用及临床效果。方法采用分组的方法选取2014年2月-2014年12月该院80例分为治疗组和对照组，治疗组采用复方异丙托溴铵联合布地奈徳雾化吸入的方法来治疗小儿毛细支气管炎，而对照组采用的是盐酸丙卡特罗口服接受治疗，并且要观察两组的各项指数变化，对小儿的哮喘时间和咳嗽的缓解情况以及肺部体征好转进行观察，选择出最佳治疗小儿毛细支气管炎的最佳方案。结果实施复方异丙托溴铵联合布地奈徳雾化吸入的方法来治疗的不良反应发生比率（7.5%）明显低于采用盐酸丙卡特罗口服接受常规治疗的对照组(32.5%)，差异有统计学意义（P<0.05），治疗组的临床效果最佳总有效率为97.5%，，远远高于对照组的87.5%。结论复方异丙托溴铵联合布地奈德雾化吸入治疗小儿毛细支气管炎是最好的治疗方案，能够有效的缓解病情，并且对小儿没有生命安全方面的影响，可以放心接受治疗，在治疗过程中比较安全。
目的分析瞭解複方異丙託溴銨聯閤佈地奈德霧化吸入治療小兒毛細支氣管炎的療效和作用及臨床效果。方法採用分組的方法選取2014年2月-2014年12月該院80例分為治療組和對照組，治療組採用複方異丙託溴銨聯閤佈地奈徳霧化吸入的方法來治療小兒毛細支氣管炎，而對照組採用的是鹽痠丙卡特囉口服接受治療，併且要觀察兩組的各項指數變化，對小兒的哮喘時間和咳嗽的緩解情況以及肺部體徵好轉進行觀察，選擇齣最佳治療小兒毛細支氣管炎的最佳方案。結果實施複方異丙託溴銨聯閤佈地奈徳霧化吸入的方法來治療的不良反應髮生比率（7.5%）明顯低于採用鹽痠丙卡特囉口服接受常規治療的對照組(32.5%)，差異有統計學意義（P<0.05），治療組的臨床效果最佳總有效率為97.5%，，遠遠高于對照組的87.5%。結論複方異丙託溴銨聯閤佈地奈德霧化吸入治療小兒毛細支氣管炎是最好的治療方案，能夠有效的緩解病情，併且對小兒沒有生命安全方麵的影響，可以放心接受治療，在治療過程中比較安全。
목적분석료해복방이병탁추안연합포지내덕무화흡입치료소인모세지기관염적료효화작용급림상효과。방법채용분조적방법선취2014년2월-2014년12월해원80례분위치료조화대조조，치료조채용복방이병탁추안연합포지내덕무화흡입적방법래치료소인모세지기관염，이대조조채용적시염산병잡특라구복접수치료，병차요관찰량조적각항지수변화，대소인적효천시간화해수적완해정황이급폐부체정호전진행관찰，선택출최가치료소인모세지기관염적최가방안。결과실시복방이병탁추안연합포지내덕무화흡입적방법래치료적불량반응발생비솔（7.5%）명현저우채용염산병잡특라구복접수상규치료적대조조(32.5%)，차이유통계학의의（P<0.05），치료조적림상효과최가총유효솔위97.5%，，원원고우대조조적87.5%。결론복방이병탁추안연합포지내덕무화흡입치료소인모세지기관염시최호적치료방안，능구유효적완해병정，병차대소인몰유생명안전방면적영향，가이방심접수치료，재치료과정중비교안전。
Objective To analyze and understand the clinical curative effect of atomization inhalation of Compound Isopropyl Bromide combined with Budesonide in the treatment of capillary bronchitis in children. Methods 80 children with capillary bronchitis admitted in our hospital from February 2014 to December 2014 were divided into the treatment group and the control group. The treatment group was treated by atomization inhalation of Compound Isopropyl Bromide combined with Budesonide, and the control group was treated by Procaterol Hydrochloride Tablets orally. The changes of parameters, duration of asthma and status of relief of cough and improvement of pulmonary signs were observed in the two groups. And the best treatment regimen was selected. Results The incidence of adverse reactions of the treatment group was much lower than that of the control group(7.5%vs 32.5%) with statistically significant difference (P<0.05). The overall clinical response rate of the treatment group was much higher than that of the control group (97.5% vs 87.5%). Conclusion For capillary bronchitis in children, atomization inhalation of Compound Isopropyl Bromide combined with Budesonide is a best treatment regimen, which can effectively alleviate the patient's condition without affecting the life safety, so the treatment is safe and can be accepted unworriedly.
